August 25th 2025
Answering all the questions ophthalmologists may have ahead of the EURETINA Congress in Paris, France
August 19th 2025
The province's public health insurance scheme, Régie de l’assurance maladie du Québec (RAMQ), covers faricimab for three indications
August 15th 2025
Salvation of ocular tissues and visual acuity are dependent on early diagnosis, investigators emphasised
August 14th 2025
Highlights from the 2025 Heidelberg Engineering International SPECTRALIS Symposium—And Beyond
August 13th 2025
New financing will support the company's lead retinitis pigmentosa programme, among other projects
EURETINA 2024: Aleksandra Rachitskaya, MD, FASRS, and the Vit-Buckle Society come to Barcelona
Challenging surgical videos from the Vit-Buckle Society symposia and data on the impact of home OCT in management of nAMD
EURETINA 2024: Martin S. Zinkernagel, MD, PhD, on the future of real-world AI use
The general secretary of the European Society of Retina Specialists (EURETINA) says the future of AI is here
EURETINA 2024: Alexandra Miere, MD, PhD, sees oculomics rising to the top
Editorial advisory board member Alexandra Miere, MD, PhD, says oculomics is the next big thing in eye care
EURETINA 2024: Factors predictive of macular oedema development in patients with silicone oil tamponade
Additional previous surgeries and the duration of the SO tamponade had little or no impact
EURETINA 2024: Tyrosine kinase inhibitors and safety data for patients with non proliferative diabetic retinopathy
Veeral Sheth, MD, MBA, FASRS, FACS, discusses outcomes from the Phase 1 HELIOS trial
EURETINA 2024: Boris Stanzel, MD, shares research on fluid monitoring and fixation clouds
New research and EURETINA highlights from the director of the "underdog" eye clinic
EURETINA 2024: Kyoko Ohno-Matsui, MD, PhD, shares a keynote on cutting-edge technologies for pathologic myopia
How retinal imaging can provide clinicians a deeper understanding of myopia
EURETINA 2024: Keynote speaker Yousif Subhi, MD, PhD, on keeping patients in focus
Yousif Subhi, MD, PhD, discusses his Ophthalmologica Lecture, "Things That Matter: An Evidence-Based Approach to AMD and CSC"
EMA announces positive opinion for SB15 (OPUVIZ, Samsung Bioepis and Biogen)
The CHMP will recommend SB15, biosimilar to aflibercept (Eylea), for marketing authorisation by the European Commission
EURETINA 2024: Subretinal drusenoid deposit load and correlation with an increased risk of stroke
Research findings from Moorfields Eye Hospital also indicate SDD and drusen differ in many factors related to stroke risk
EURETINA 2024: Andrea Govetto, MD, PhD, says it takes teamwork to understand macular oedema
We spoke with Andrea Govetto, MD, PhD, winner of the inaugural Ramin Tadayoni Award at EURETINA
EURETINA 2024: Unraveling the genetic spectrum of combined retinal dystrophy and hearing impairment
Researchers in Portugal investigated Usher syndrome, Senior-Loker syndrome and other ciliopathies
EURETINA 2024: Ricardo Leitão Guerra, MD, MSc, FICO, speaks about multimodal imaging
Why having a set process for diagnostic imaging is crucial to patient outcomes
EURETINA 2024: Subretinal gene therapy improves function and structure in patients with Bothnia Dystrophy
Bothnia Dystrophy generally presents during early childhood; patients have night blindness, progressive visual loss, and subsequent legal blindness.
EURETINA 2024: Ocular involvement among patients with COVID-19 infection or vaccination
A case series illuminates neuro-ophthalmologic manifestations, retinal vascular involvement and other pathologies
EURETINA 2024: Cardio-ocular syndrome and retinal microvasculature changes in acute heart failure
The research team used spectral-domain OCT and OCT angiography imaging to study the changes in the retinal microvasculature in patients
EURETINA 2024: Efficacy results and patient preference findings from the Pagoda trial
Dr Margaret A. Chang shares data on the port delivery system with ranibizumab, and her strategy for making the most of conferences
See what our Editorial Advisory Board members are bringing to EURETINA
Spotlight on the retina specialists who make up the Eye Care Network advisory boards
Industry preview: Ophthalmic companies bring updates, new research findings to EURETINA
Businesses in the retina care space tease new technologies and cutting-edge therapeutics
Celebrate World Retina Day at the 2024 EURETINA Congress
As part of the Barcelona meeting, retina specialists can recognise the awareness day early
24th EURETINA Congress: The art of retina on stage in Barcelona
Focus on collaboration, career development and innovation
Remembering a legend: EURETINA members speak about the Ramin Tadayoni Award
The Ramin Tadayoni Award supports the next generation of retina researchers while paying tribute to a leader in the field
The digital OR: Retina care of tomorrow
The future of the tech-forward surgical suite
Research findings illustrate role of vitamin D in preventing retinal vein occlusion
A meta-analysis indicates a "significant association" between vitamin D deficiency and increased risk of RVO
A field guide to optic disc drusen
Clinical associations, imaging strategies and establishing a differential diagnosis from pseudopapilloedema
Ranibizumab biosimilar LUBT010 (Lupin) reaches primary endpoint in global Phase 3 study
Lupin has successfully completed a clinical study of LUBT010, a ranibizumab biosimilar to Lucentis
ASRS abroad: Retina specialists converge in Sweden
A postcard from the American Society of Retina Specialists meeting in Stockholm
European Commission issues approval for faricimab (Vabysmo) for treatment of retinal vein occlusion
In a press release, Roche noted that up to 60% of patients were able to extend treatment intervals to 3 or 4 months
Kiora Pharmaceuticals receives Orphan Medicinal Product Designation for KIO-301
The EMA issued a designation for the small molecule photoswitch, which targets inherited retinal diseases including retinitis pigmentosa
ASRS 2024: Real-world treatment outcomes from a study of patients with retinal vein occlusion
Consultant ophthalmologist Christiana Dinah, BSc, MB BS, MRes, presented research findings on retinal vein occlusion in the United Kingdom